Psychedelics Tacoma joins Seattle in making psychedelics law enforcement lowest priority The resolution passed on Jan. 28 also aims to push for statewide decriminalization Rowan DunneFebruary 6, 2025
Psychedelics GH Research skyrockets on 5-MeO-DMT drug’s depression treatment breakthrough Shares surged by nearly 125% during pre-market hours Rowan DunneFebruary 3, 2025
Psychedelics Optimi Health produces largest-ever batch of MDMA capsules The MDMA, psilocybin and functional mushroom producer also just scooped more funding Rowan DunneJanuary 29, 2025
Psychedelics Edmonton’s new psychedelic therapy clinic helps residents soothe the winter blues It offers ketamine, psilocybin, and MDMA therapy sessions Rowan DunneJanuary 27, 2025
Psychedelics MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug The biopharma operator's lead drug candidate, MB22001, was created for microdosing Rowan DunneJanuary 24, 2025
Psychedelics University College London undertakes extensive DMT study aimed at treating alcohol abuse The renowned institution claims this is the largest-ever psychedelic brain imaging study of its variety Rowan DunneJanuary 20, 2025
Psychedelics Denver Shroom Fest set to return after successful debut in 2024 Last year's event was a vibe Rowan DunneJanuary 16, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
Psychedelics Colorado set to ring in new year with regulated magic mushroom therapy A law passed by voters in late 2022 is coming into force on Jan. 1 Rowan DunneDecember 30, 2024
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024